PD-155 Molecular markers such as EGFR and kRAS mutations...

Lung Cancer 2005 / 7 Vol. 49

PD-155 Molecular markers such as EGFR and kRAS mutations aspredictors of sensitivity to erlotinib in patients (pts) with NSCLC: Exploratory subanalyses of TALENT, a phase III trial

Reck, M., Heller, A., Foernzler, D., Moecks, J., Ward, C., De Rosa, F., Sauter, G., Brennscheidt, U., Gatzemeier, U.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80488-x
Date:
July, 2005
File:
PDF, 149 KB
english, 2005
Conversion to is in progress
Conversion to is failed